Brian Alexander, Foundation Medicine CEO (LinkedIn)
Bristol Myers, Foundation Medicine expand collaboration to ex-Turning Point cancer drug
Roche subsidiary Foundation Medicine has expanded a Big Pharma collaboration around its companion diagnostic and a potential future blockbuster.
The diagnostics outfit put out word …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.